Intek Diagnostics Inc.

Basic Information

1450 Rollins Road
Burlingame, CA, 94010

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. IMMUNOHISTOCHEMICAL STUDY OF ORAL DYSPLASIA AND CARCINOMA

    Amount: $126,000.00

    THERE ARE NO SENSITIVE IN VITRO DIAGNOSTIC TESTS FOR THE DETECTION OF ORAL DYSPLASIA OR CARCINOMA. ALTHOUGH FRANK MALIGNANCIES ARE MORE READILY DIAGNOSED, THERE ARE INCONSISTENCIES IN THE CATEGORIZING ...

    SBIR Phase II 1987 Department of Health and Human Services
  2. IMMUNOHISTOCHEMICAL STUDY OF ORAL DYSPLASIA AND CARCINOMA

    Amount: $50,000.00

    N/A

    SBIR Phase I 1986 Department of Health and Human Services
  3. THERE ARE NO SENSITIVE METHODS FOR THE DIAGNOSIS OF METASTASES AND LYMPH NODE INVOLVEMENT IN HUMAN SQUAMOUS CELL CARCINOMA (SCC) OF THE HEAD AND NECK REGION.

    Amount: $50,000.00

    THERE ARE NO SENSITIVE METHODS FOR THE DIAGNOSIS OF METASTASES AND LYMPH NODE INVOLVEMENT IN HUMAN SQUAMOUS CELL CARCINOMA (SCC) OF THE HEAD AND NECK REGION. RADIOIMMUNODETECTION IS CAPABLE OF HIGH RE ...

    SBIR Phase I 1985 Department of Health and Human Services
  4. INTEK DIAGNOSTICS, INC.

    Amount: $50,000.00

    INTEK DIAGNOSTICS, INC. (FORMERLY CARCINEX, INC.) IS A SMALL BUSINESS CORPORATION FUNDED TO DEVELOP AND MARKET NEW METHODS TO DIAGNOSE, STAGE, AND TREAT SQUAMOUS CELL CARCINOMAS. INTEK DIAGNOSTICS HAS ...

    SBIR Phase I 1985 Department of Health and Human Services
  5. INTEK HAS DEVELOPED OVER 20 VERY PROMISING TUMOR-ASSOCIATED AND POSSIBLY TUMOR-SPECIFIC MURINE MONOCLONAL ANTIBODIES AGAINST SQUAMOUS CELL CARCINOMA (SCC) TUMORS.

    Amount: $50,000.00

    INTEK HAS DEVELOPED OVER 20 VERY PROMISING TUMOR-ASSOCIATED AND POSSIBLY TUMOR-SPECIFIC MURINE MONOCLONAL ANTIBODIES AGAINST SQUAMOUS CELL CARCINOMA (SCC) TUMORS. THERE ARE CURRENTLY NO IMMUNOLOGICAL ...

    SBIR Phase I 1985 Department of Health and Human Services
  6. METHODS ARE NOW AVAILABLE FOR IDENTIFYING AND PURIFYING A VAST ARRAY OF ANTIGENS EXPRESSED ON TUMOR CELLS.

    Amount: $50,000.00

    METHODS ARE NOW AVAILABLE FOR IDENTIFYING AND PURIFYING A VAST ARRAY OF ANTIGENS EXPRESSED ON TUMOR CELLS. THE PURPOSE OF THE PROPOSED STUDIES IS TO DEVELOP METHODS FOR SENSITIZING T CELLS TO ANTIGENS ...

    SBIR Phase I 1985 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government